MIF modulates various inflammatory and immune responses, which has prompted the characterization of MIF as a biomarker in several chronic inflammatory diseases, such as rheumatoid arthritis, systemic sclerosis, and inflammatory bowel disease [11,12,13]. The gene discussed is MIF; the disease is systemic sclerosis.